IL17A and neoplasm: Numasaki et al. have shown that IL-17 promotes tumor cell growth in vivo by enhancing angiogenesis in mice with MCA205/IL-17 tumors, while angiogenic activity was markedly suppressed by a neutralizing IL-17 monoclonal antibody (112).